SCHEMBL7200290

SCHEMBL7200290

CC(=O)O/C=C\CCOC(C)=O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRM5 P08912 2/20 0.43
CHRM1 P11229 2/20 0.43
CHRM3 P20309 2/20 0.43
ALOX15 P16050 2/20 0.43
ALDH1A1 P00352 5/20 0.41
SMN1; SMN2 Q16637 2/20 0.40
PGR P06401 1/20 0.40
CHRM2 P08172 1/20 0.40
CHRM4 P08173 1/20 0.40
HTR1A P08908 1/20 0.40
CHRNB2 P17787 1/20 0.40
TBXA2R P21731 1/20 0.40
CHRNB4 P30926 1/20 0.40
CHRNA3 P32297 1/20 0.40
CHRNA7 P36544 1/20 0.40
CHRNA4 P43681 1/20 0.40
CHRNA10 Q9GZZ6 1/20 0.40
CHRNA9 Q9UGM1 1/20 0.40
TSHR P16473 1/20 0.40
GALR3 O60755 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL74777 1.00 CHRM5 (0.43) CHRM5CHRM1CHRM3ALOX15ALDH1A1
SCHEMBL74778 1.00 CHRM5 (0.43) CHRM5CHRM1CHRM3ALOX15ALDH1A1
SCHEMBL11058403 0.88 CHRM5 (0.41) CHRM5CHRM1CHRM3ALOX15ALDH1A1
SCHEMBL29801137 0.88 ALDH1A1 (0.48) CHRM5CHRM1CHRM3ALOX15ALDH1A1
SCHEMBL6674430 0.86 ALOX15 (0.40) CHRM5CHRM1CHRM3ALOX15ALDH1A1
SCHEMBL5505267 0.84 ALOX15 (0.44) CHRM5CHRM1CHRM3ALOX15ALDH1A1
SCHEMBL1906626 0.84 ALDH1A1 (0.50) CHRM5CHRM1CHRM3ALOX15ALDH1A1
SCHEMBL19333596 0.84 ALDH1A1 (0.33) CHRM5CHRM1CHRM3ALOX15ALDH1A1
SCHEMBL1906628 0.84 ALDH1A1 (0.50) CHRM5CHRM1CHRM3ALOX15ALDH1A1
SCHEMBL13563053 0.83 ALOX15 (0.43) CHRM5CHRM1CHRM3ALOX15ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230419761-A1 MOVING BODY QUEUE MANAGEMENT SYSTEM AND MOVING BODY QUEUE MANAGEMENT METHOD HITACHI, LTD. (JP) 2023-12-28 US disclosed
WO-2022137656-A1 MOVING BODY QUEUE MANAGEMENT SYSTEM AND MANAGEMENT METHOD 株式会社日立製作所 2022-06-30 WO disclosed
US-20220087293-A1 PRODUCTION OF SOLUBLE PROTEIN SOLUTIONS FROM PULSES BURCON NUTRASCIENCE (MB) CORP. (CA) 2022-03-24 US disclosed
WO-2012116977-A1 PROCESS FOR THE PREPARATION OF 3-METHYLENE-γ-BUTYROLACTONE DSM IP ASSETS B.V. (NL) 2012-09-07 WO disclosed
US-6541660-B2 Chemical intermediates for vitamin A biosynthesis BASF AKTIENGESELLSCHAFT (DE) 2003-04-01 US disclosed
EP-1247794-A2 Process for the production of C5-acetate for the synthesis of vitamin A BASF AKTIENGESELLSCHAFT (DE) 2002-10-09 EP disclosed
US-4806679-A GAS OR LIQUID PHASE CATALYSIS WITH ZEOLITE; INTERMEDIATES BASF AKTIENGESELLSCHAFT (DE) 1989-02-21 US disclosed
EP-0132737-B1 PROCESS FOR THE ISOMERIZATION OF DIACYLOXYBUTENES BASF Aktiengesellschaft (DE) 1988-01-07 EP disclosed
EP-0132737-A2 Process for the isomerization of diacyloxybutenes BASF Aktiengesellschaft (DE) 1985-02-13 EP disclosed